MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0110608
Serigen Mediproducts Private Limited - life sciences in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹91.08 Lakh
▲ 338% YoY
Net loss · FY 2025
₹3.41 Cr
Net margin -373.9%
EBITDA · FY 2025
-₹3.25 Cr
EBITDA margin -356.8%
Authorised capital
₹2.8 Lakh
Registered with MCA
Paid-up capital
₹1.91 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Serigen Mediproducts Private Limited
Data last updated:
Serigen Mediproducts Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 03 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2015PTC153912. Its GSTIN is 27AAGCB1775J1ZG (Maharashtra).
The company has an authorised share capital of ₹2.8 Lakh and a paid-up capital of ₹1.91 Lakh. It was formerly known as Biolmed Innovations Private Limited. It is led by directors including Priti Jay Rao and Anuya Amol Nisal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹91.08 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.41 Cr (net margin -373.9%) and EBITDA of -₹3.25 Cr (EBITDA margin -356.8%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 76% over five years.
The company is associated with 2 brands: Serigen and BiolMed Innovations. The company has 7 deals on record (3 secondary share transfers, 2 funding rounds, 2 rights issues), with disclosed funding of ₹8.8 Cr; the latest was in March 2023.
Serigen Mediproducts Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0110608). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biolmedinnovations.com.
Company details
CIN U74900PN2015PTC153912
Registration Number 153912
Incorporation Date 03 February 2015
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0110608
Recognitions & Rankings of Serigen Mediproducts
Contact details
Serigen Mediproducts Private Limited's registered office is in Pune, Maharashtra. Its website is biolmedinnovations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 39 S No 44 Electronic Co – Operative Industrial Estate, Satara Road, Pune, Maharashtra, India – 411009
- IndustryLife Sciences, Biotechnology
To see the full contact details of Serigen Mediproducts Private Limited, buy the company report.
Comprehensive company report
Serigen Mediproducts Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Serigen Mediproducts operates two associated brands: Serigen and BiolMed Innovations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of protein-based tissue regeneration products for orthopedics | serigenmed.com | |
| Medical devices for multiple therapeutic areas are researched and manufactured. | biolmedinnovations.com |
Business activity
The main business activity of Serigen Mediproducts is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Serigen Mediproducts Private Limited, buy the company report.
Financials of Serigen Mediproducts Private Limited
FY 2025 filings availableSerigen Mediproducts Private Limited reported revenue of ₹91.08 Lakh (up 338% YoY) for FY 2025.
Revenue · FY 2025
₹91.08 Lakh ▲ 338%
Net loss · FY 2025
₹3.41 Cr margin -373.9%
EBITDA · FY 2025
-₹3.25 Cr margin -356.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 338%
3 years · compounded
▲ 13%
5 years · compounded
▲ 76%
EBITDA CAGR growth
1 year
▼ 76%
3 years · compounded
▼ 48%
5 years · compounded
▼ 67%
Revenue has grown at a compounded annual rate (CAGR) of 76% over five years, including 338% growth in the latest year. EBITDA fell 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.25 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.41 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -356.8% | ||||
| Net Profit Margin | -373.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Serigen Mediproducts Private Limited, buy the company report.
Board of directors of Serigen Mediproducts Private Limited
Serigen Mediproducts has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priti Jay Rao | Director | 15 Jan 2020 | 6 Years 9 Months | Current |
| Anuya Amol Nisal Also directs: Aic Iiser Pune Seed Foundation | Director | 03 Feb 2015 | 11 Years 9 Months | Current |
| Premnath Venugopalan Also directs: Entrepreneurship Development Center | Director | 03 Feb 2015 | 11 Years 9 Months | Current |
| Sarika Saxena | Nominee Director | 05 Sep 2024 | 2 Years 1 Months | Current |
| Swati Govind Shukla | Director | 05 Sep 2024 | 2 Years 1 Months | Current |
Auditor
Serigen Mediproducts Private Limited is audited by CHARKHA AND GATTANI for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHARKHA AND GATTANI | FY 2022 | 140607W |
Shareholding
The shareholding of Serigen Mediproducts Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Serigen Mediproducts Private Limited, buy the company report.
Deals & funding
Serigen Mediproducts Private Limited has 7 deals on record (3 secondary share transfers, 2 funding rounds, 2 rights issues), with disclosed funding of ₹8.8 Cr; the latest was in March 2023.
Total deals
7
Secondary share transfers
3
Funding rounds
2
Rights issues
2
Disclosed funding
₹8.8 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Funding round | ₹5.8 Cr | Investors: Colossa Ventures, 3 individuals |
| Jul 2022 | Rights issue | ₹1.5 Cr | Investors: 2 individuals |
| Jan 2020 | Funding round | ₹3 Cr | Investors: Pandit Nominees Pty Limited, an individual |
| Feb 2019 | Rights issue | ₹98.4 Lakh | Investors: 2 individuals |
| May 2018 | Secondary share transfer | Undisclosed | Buyer: Biolmed Employee Welfare Trust Seller: 2 individuals |
To see the full deal history of Serigen Mediproducts Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Serigen Mediproducts Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Serigen Mediproducts Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Serigen Mediproducts has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCB1775J1ZG | Maharashtra | Active | 01 Dec 2020 |
To see the full GST registrations and return filing status of Serigen Mediproducts Private Limited, buy the company report.
Recent activity
Serigen Mediproducts Private Limited has 9 board changes on record since 2015: 5 appointments and 4 cessations. The latest: Sarika Saxena was appointed as Nominee Director on 05 Sep 2024.
AGM
Serigen Mediproducts Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Serigen Mediproducts Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Sarika Saxena was appointed as Nominee Director.
Appointed
Swati Govind Shukla was appointed as Director.
Ceased
Swati Govind Shukla ceased to be Additional Director.
Ceased
Uday Chatterjee ceased to be Nominee Director.
Ceased
Priti Dilip Rathi ceased to be Nominee Director.
Ceased
Priti Jay Rao ceased to be Additional Director.
Appointed
Priti Jay Rao was appointed as Director.
Appointed
Anuya Amol Nisal was appointed as Director.
Appointed
Premnath Venugopalan was appointed as Director.
Incorporation
03 Feb 2015
Serigen Mediproducts Private Limited was registered on 03 Feb 2015 with Roc Pune & aged 11 years 9 months as per MCA records.
News
Frequently asked questions
Serigen Mediproducts is an active private limited company based in Pune, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 03 February 2015 (11+ years old) and is registered under CIN U74900PN2015PTC153912.
Serigen Mediproducts has 5 current directors:
- Priti Jay Rao - Director
- Anuya Amol Nisal - Director
- Premnath Venugopalan - Director
- Sarika Saxena - Nominee Director
- Swati Govind Shukla - Director
The latest financial statements of Serigen Mediproducts on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Serigen Mediproducts is 27AAGCB1775J1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Serigen Mediproducts is U74900PN2015PTC153912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Serigen Mediproducts was incorporated on 03 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pune.
Serigen Mediproducts has 7 deals on record (3 secondary share transfers, 2 funding rounds, 2 rights issues), with disclosed funding of ₹8.8 Cr; the latest was in March 2023.
Sarika Saxena was appointed as Nominee Director on 05 Sep 2024. Swati Govind Shukla was appointed as Director on 05 Sep 2024. Swati Govind Shukla ceased to be Additional Director on 05 Sep 2024. Serigen Mediproducts has 9 board changes on record in total.
Yes, Serigen Mediproducts is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0110608).
Serigen Mediproducts can be reached through the website biolmedinnovations.com. Its registered office is in Pune, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages